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Rapid excitatory neurotransmission i the central nervous system (CNS) is mediated predominantly by synaptically released L-glutamate which 
activates cation selective channels with different kinetic and ion conductance properties. Studies with cloned glutamate receptor channels helped 
delineate the functional properties of channels defined in subunit composition. Moreover, molecular studies have revealed novel genetic mechanisms 
controlling the expression of important structural channel determinants. 
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1. INTRODUCTION 
Only since the early sixties has the common metabo- 
lite, L-glutamate, been recognized for its role as a ubiq- 
uitous excitatory neurotransmitter in the brain. Over 
the past 5 years ingenious expression cloning studies 
have been instrumental in isolating receptors [l], chan- 
nels [2,3] and transporters [4] interacting with gluta- 
mate. The structures of these major components of the 
synaptic excitatory signalling machinery form a world 
of their own, being at best very distantly related to 
comparable structures for other prominent amino acid- 
related transmitters, such as GABA, glycine, and sero- 
tonin. Thus, glutamate activates G-protein-coupled, 
metabotropic receptors that have seven putative trans- 
membrane segments like other 7TM receptors. How- 
ever, metabotropic glutamate receptors display no se- 
quence similarity to other members of the extensive 
G-protein-coupled receptor family [ 1,5]. Similarly, fol- 
lowing the molecular characterization of a gene family 
encoding transporters for neurotransmitters uch as 
GABA, glycine, and biogenic amines [6], the cloning of 
glutamate transporters [4,7] revealed that these latter 
are molecularly and mechanistically distinct from previ- 
ously characterized transporters. Regarding ionotropic 
glutamate receptors, they, like other neurotransmitter- 
activated channels, are composed of subunits, giving 
them a modular design and allowing for functional di- 
versity by select subunit combinations (Fig. 1, Table I). 
However, these receptors are very distinct in size, se- 
quence, and conserved sequence patterns, from the well- 
characterized nicotinic acetylcholine/GABA, receptor 
superfamily (reviewed in [8]). They may even differ in 
transmembrane topology and subunit stoichiometry. 
Ionotropic glutamate receptors are conveniently cate- 
gorized into N-methyl-D-aspartate (NMDA) receptors, 
L-a-amino-3-hydroxy-5-methyl-4-isoxazole propionate 
(AMPA) receptors and kainate receptors (Table I). This 
pharmacological distinction reflects selective agonist 
properties of exogenous, synthetic compounds on the 
various glutamate receptor channels [9]. As of today, 16 
cDNAs encoding ionotropic glutamate receptor sub- 
units have been cloned (reviewed in [lo]). Using heterol- 
ogous expression systems and biophysical channel anal- 
ysis, certain rules governing subunit combinations as- 
sembling into functional glutamate-activated channels 
could be established (Table I), and new properties of 
these channels emerged. Our review summarizes alient 
molecular and functional features of cloned channels, 
and speculates on an unusual control mechanism that 
selectively alters gene-encoded eterminants for gluta- 
mate-evoked Ca2’ permeability. 
2. NMDA RECEPTORS 
Correspondence address. R. Sprengel, Laboratory of Molecular Neu- 
roscience, Center for Molecular Biology (ZMBH), Heidelberg Univer- 
sity, INF 282, D-6900 Heidelberg, Germany. 
NMDA receptors are uniquely designed to function 
as molecular coincidence detectors (reviewed in [l 11). 
Under normal synaptic activity these channels contrib- 
ute little to fast signal transmission owing to a Mg2+ ion 
blocking the NMDA channel pore. In depolarized cells, 
the Mg2+ block is released and the NMDA channel can 
be fully activated. Hence, NMDA receptor activity is a 
sensor for synchronous activity states of the pre- and 
postsynaptic ell. This activity plays a role in conjunc- 
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Fig. 1. Schematic representation of ionotropic glutamate receptor subunits in comparison to subunits of other chemically gated ion channels. 
Subunits for NMDA, AMPA and kainate receptor subtypes of glutamate receptors are at least 900 amino acids in length. The NR2 subunits of 
NMDA receptors have larger sizes (Z 1,300 residues) because of extended COOH-termini. All subunits contain four hydrophobic segments (Ml 
to M4, black boxes) which are involved in determining the transmembrane topology, and which participate in ion channel formation. In AMPA 
receptor subunit GluR-B and kainate receptor subunits GluR-5 and -6 select residues in Ml and M2 are controlled by RNA editing (arrows). Many 
subunits occur in several splice forms, with additional or substituted sequences present in the N-terminal (extracellular) egion, in the M3 to M4 
loop, and in the hydrophilic COOH-terminal part. The stippled area denotes conserved sequences among subunits of different ionotropic glutamate 
receptor types. The distribution of conserved sequences in these subunits contrasts with the extent of such conserved regions (stippled) in subunits 
of the superfamily of GABA, and nicotinic acetylcholine receptors, which differ markedly in size (= 450 residues) from glutamate receptor channels. 
tion with the characteristically high Ca” permeability 
and long activation times of the ion channel. Ca2’ influx 
through NMDA channels is thought to trigger impor- 
tant physiological processes, and is held responsible for 
certain pathophysiological processes. One prominent 
example is the activity-dependent enhancement of syn- 
aptic efficacy, a process termed long-term potentiation 
(LTP) and viewed as a synaptic model for certain types 
of memory [ 11,121. A related phenomenon concerns the 
damage that glutamate excessively released in e.g. is- 
chemic conditions can do to neurons. Most ischemic ell 
death appears to be wrought by an excess of Ca2+ influx 
through NMDA receptors (reviewed in [13]). 
The molecular biology of this receptor indicates that 
it contains two types of subunits. One subunit 
(NMDARl, abbr. NRI) occurs in virtually every neu- 
ron [3], and is likely to be a constituent of all NMDA 
receptor subtypes. In vitro expression of this subunit 
alone generates (at a reduced efficiency) functional 
channels that display key properties of NMDA recep- 
Table I 
Subunits and characteristics of glutamate receptor channels 
Subunits Alternative nomenclature Receptor 
type 
Heteromeric 
assembly 
Functional 
characteristics 
GluR-A 
GluR-B 
GluR-C 
GluR-D 
GluR-5 
GluR-6 
GluR-7 
KA-1 
KA-2 
NR-1 
NR-2A 
NR-2B 
NR-2C 
NR-2D 
AMPA 
Kainate 
(high affinity) 
CluR-1 al 
GluR-2 a2 
GluR-3 a3 
GluR-4 a4 
;: 
83 
Yl 
Yl 
GluR-A to -D; 
most native 
receptors contain 
GluR-B 
GluR-5 to -7 
with KA-1, -2 
rapid kinetics, low Ca2’ permeability, 
small conductance; 
glutamate activates desensitizing 
current, kainate activates non-desensi- 
tizing current 
rapid kinetics, glutamate and kainate 
activate rapidly desensitizing current 
NMDA 4-l 
El 
&2 
E3 
&4 
NR-1 with 
NR-2 subunits 
slow kinetics, large conductance, 
little desensitization, high Ca*’ 
permeability, voltage-dependent 
Mg2+ block, glycine as co-agonist 
91 
Volume 325, number 1,2 FEBS LETTERS June 1993 
tors. Of the other subunit, currently four variants 
(NR2A to D) have been molecularly cloned, each en- 
coded by its own gene with a unique expression pattern 
in the brain [14-161. These subunits fail to form func- 
tional homomeric channels but impart on NMDA re- 
ceptors containing them particular subtype-specific 
properties, including different strengths of M$+ block- 
ade, and pharmacological differences (e.g. differential 
glycine sensitivity). There are also kinetic differences 
since upon removal of agonist, whole-cell currents 
decay with distinct, slow time courses. It is believed that 
the subtype-specific, slow offset kinetics of NMDA cur- 
rents have physiological impact with respect to the 
amount of Ca2’ flux through the channel, after termina- 
tion of presynaptic glutamate release. Additional mo- 
lecular diversity of NMDA receptors emerges from the 
fact that the common channel subunit NRl can exist in 
different forms generated by alternative splicing [17]. 
Functional differences for these forms need deter- 
mining. 
Although NRl and NR2 subunits have little sequence 
similarity (18% identity) they share an important molec- 
ular determinant in the form of an asparagine residue, 
located in what appears to be a channel forming region 
(Fig. 1). Site-directed mutagenesis combined with bio- 
physical measurements of recombinantly expressed 
heteromeric receptor channels reveals that this asparag- 
ine residue determines the two most distinctive proper- 
ties of NMDA receptors; high Ca2+ permeability and 
voltage-dependent Mg2+ block. These properties are 
also evident in homomeric NRl receptors [3]. However, 
in heteromeric NR l-NR2 receptor channels, substitut- 
ing the asparagine of NRl affects predominantly the 
Ca2’ permeability of the channel, whereas a substitution 
of the asparagine in NR2 subunits changes the Mg2+ 
block [ 181. 
3. AMPA RECEPTORS 
These prominent glutamate receptor channels in 
brain are distinguished from other ionotropic glutamate 
receptors by possessing a high-affinity binding site for 
[3H]AMPA. AMPA receptor channels are primarily re- 
sponsible for fast excitatory neurotransmission by glu- 
tamate, and co-exist with NMDA receptors in many 
synapses (reviewed in [19]). The hallmarks of the 
AMPA channel are fast kinetics [20,21] and low perme- 
ability to divalent cations [21,22]. 
In molecular terms, AMPA receptors assemble from 
a pool of four subunits (GluR-A to -D) which share a 
high degree of sequence identity (70%) [23,24]. Exactly 
how many subunits enter functional receptor channels 
has yet to be determined. Co-expression in heterologous 
systems of two subunits generates channels with proper- 
ties much like their neuronal counterparts [21], but only 
if one subunit is GluR-B. GluR-B dominates the gating, 
ion conductance and permeability properties of AMPA 
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receptors [25,26]. GluR-B-containing AMPA receptors 
are characterized by linear current-voltage (Z- v) 
relations and low Ca2’ permeability like native 
channels, whereas AMPA receptors lacking GluR-B are 
Ca2+ permeable and possess more complex, doubly rec- 
tifying Z-V relations. The functional dominance of 
GluR-B may be reflected in the fact that its mRNA is 
found in most neurons. Hence, the expression level of 
the GluR-B gene determines to a major degree the low 
divalent permeability of glutamate-gated AMPA recep- 
tors in neural cells. This notion has been confirmed by 
a study of Bergmann glial cells which express AMPA 
receptor channels lacking GluR-B. These cells show 
considerable glutamate-activated Ca2’ entry and gluta- 
mate-evoked whole-cell currents with a doubly rectify- 
ing Z-V relationship [27,28]. 
The structure mediating dominance of GluR-B in 
AMPA receptor channels is a positively charged amino 
acid residue (arginine, R) in a putative channel-forming 
region of this subunit [29,30]. The other three AMPA 
receptor subunits carry an uncharged glutamine (Q) 
residue in the homologous position. Interestingly, this 
position (Q/R site) is occupied by asparagine in the 
homologous site of NMDA receptor channels [3,14]. As 
detailed above, this asparagine in NMDA receptor sub- 
units is essential for high Ca2’ permeability and for 
voltage-dependent Mg2+ block. Indeed, AMPA recep- 
tors engineered to contain an asparagine in their Q/R 
site have high Ca2’ permeability and low Mg2+ permea- 
bility, reminiscent of NMDA receptors [30,31]. This 
finding highlights the functionally homologous design 
of ionotropic glutamate receptors in their channel- 
forming region. The charge and size of a single amino 
acid side chain in a critical channel site determine the 
particular ion conductance and permeability properties 
that characterize the different glutamate-activated 
channels (Table I). 
The presence of the dominant arginine residue in the 
critical Q/R site of GluR-B cannot be deduced from 
sequence analysis of the GluR-B gene. In fact, judging 
from the gene sequence, a glutamine residue should 
occupy the Q/R site of GluR-B. The vast majority of 
GluR-B mRNA molecules, however, contain an argin- 
ine codon, as predicted from cDNA analysis. Indeed, 
99.99% of all GluR-B subunits in brain carry an argin- 
ine residue in the Q/R site, consistent with the properties 
of native AMPA receptor channels. The discrepancy 
between gene and cDNA has been resolved by postulat- 
ing that a single nucleotide in GluR-B RNA is modified, 
thereby generating the CGG codon for arginine from a 
genomic CAG codon for glutamine. This curious proc- 
ess of converting a glutamine to an arginine codon (pos- 
sibly by deamidation of adenosine) constitutes the first 
example of RNA editing in the brain [32]. The physio- 
logical consequences of a defect in this unusual genetic 
control mechanism remain speculative. AMPA receptor 
channels with increased Ca2+ permeability should be a 
Volume 325, number 1,2 FEBS LETTERS June 1993 
direct consequence, possibly followed by delayed cell 
death for populations of neurons unable to cope with 
an increased Ca*+ load. 
4. KAINATE RECEPTORS 
Kainate is a potent neurotoxin that has agonist prop- 
erties on some subtypes of glutamate receptor channels. 
It activates in AMPA receptors a non-desensitizing cur- 
rent. It activates desensitizing currents in a different 
glutamate receptor that displays high-affinity binding of 
[3H]kainate. The in vivo role of the latter receptor chan- 
nel, designated high-affinity kainate receptor, is unre- 
solved. Subunits for such receptors have been cloned 
and shown to be expressed widely in the CNS. However, 
no evidence for desensitizing current components 
evoked by kainate in patches from somata of central 
neurons has been forthcoming. It is now thought that 
these channels may be located exclusively in dendrites, 
and immunocytochemical evidence supports this 
[33,34]. 
Two subunit families have been identified by molecu- 
lar cloning from which high-affinity kainate binding 
sites can be reconstituted in heterologous expression 
systems (Fig. 1, Table I). Subunits of one family (GluR- 
5,-6-7) form functional heteromeric channels when 
combined with members of the other subunit family 
(KA-l,-2) but can also form homomeric channels. Ho- 
momeric channel formation has not been seen for KA- 1 
nor for KA-2, and these two subunits do not form heter- 
omeric channels when combined ([35]; reviewed in [36]). 
The two subunits GluR-5 and -6 are affected by site- 
specific RNA editing, similar to GluR-B. Analysis re- 
veals that between 30 and 70% of RNA encoding these 
subunits is edited in the Q/R site [32]. For GluR-6, two 
additional edited sites have been identified that are lo- 
cated in another membrane-spanning region (M 1). 
GluR-6 has the distinction of occuring in eight molecu- 
lar variants with respect to edited positions alone [37]. 
Several of these variants, when analyzed in a homo- 
meric configuration by recombinant expression, show 
differences in Ca”/Cs’ reversal potentials of glutamate- 
activated whole-cell currents [37]. Thus, there is a dis- 
tinct possibility that brain cells can regulate the RNA 
editing of those nucleotides which code for structures 
mediating or preventing glutamate-evoked Ca*’ influx. 
5. OUTLOOK 
Studies with defined, recombinantly expressed ion- 
otropic glutamate receptors have revealed functional 
properties that are not readily obtained from studying 
such receptors in native brain membranes. One reason 
for this is that, in native membranes, different channel 
types and their subtypes co-exist, and pharmacological 
means for their dissection may not be always available. 
Alternatively, modeling excitatory synaptic responses 
from functional properties of recombinantly expressed 
single receptors requires knowledge of the receptor pop- 
ulations and their true subunit composition in the 
postsynaptic membrane. Hence, matching results from 
recombinant expression studies with those obtained 
from native membranes is obligatory. Research efforts 
will be directed towards elucidating regulatory mecha- 
nisms underlying channel expression in select cell popu- 
lations of the brain. In particular, the involvement of 
different molecular types of glutamate receptor chan- 
nels in the various phenomena of synaptic plasticity 
needs investigating. Such studies may also uncover a 
physiological role for RNA editing. 
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